Market share of major cold medicine in public healthcare market in China H1 2022
In the first half of 2022, Yiling Pharmaceutical's Lianhuaqingwen granules or capsules held the largest share of almost 36 percent in the public healthcare market in China, ranked first among cold medicines. Meanwhile, the market shares of other cold medicines were all less than seven percent.